All In MedTech

FDA Clearance Tracker · P130022-S034

Senza Spinal Cord Stimulation (SCS) System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 21, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 21, 2021

Approved

Time to decision

368 days

Received May 18, 2020. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P130022-S034
Device name
Senza Spinal Cord Stimulation (SCS) System
Applicant location
Redwood City, CA
Received
May 18, 2020
Decided
May 21, 2021
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P130022

Device type

Device class
Class III

Every decision under product code LGW

FDA's approval statement

As written in FDA's record.

Approval for the addition of an alternative site, Cirtec Medical Corporation Free Zone Coyol, Building 11 Costa Rica CR 20101, as a back up to the primary site Cirtec Medical, formerly known as Stellar, Brooklyn Park, MN for the manufacturing of the percutaneous lead components to accommodate higher volume manufacturing.

Source documents

Other decisions for Nevro Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.